{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:10:56Z","timestamp":1783343456800,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01836-0","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T03:58:05Z","timestamp":1737691085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the two treatment methods in primary hyperparathyroidism due to solitary parathyroid adenoma, Ultrasound-guided percutaneous alcohol ablation vs. parathyroidectomy: a randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammad","family":"Eslamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Firouzfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Pouramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Iraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Kolahdouzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"1836_CR1","doi-asserted-by":"publisher","first-page":"204062232110159","DOI":"10.1177\/20406223211015965","volume":"12","author":"AK Islam","year":"2021","unstructured":"Islam AK. Advances in the diagnosis and the management of primary hyperparathyroidism. Ther Adv Chronic Dis. 2021;12:20406223211015965. https:\/\/doi.org\/10.1177\/20406223211015965.","journal-title":"Ther Adv Chronic Dis"},{"key":"1836_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.12659\/AJCR.911452","volume":"19","author":"I Mantzoros","year":"2018","unstructured":"Mantzoros I, Kyriakidou D, Galanos-Demiris K, Chatzakis C, Parpoudi S, Sapidis N, Loutzidou L, Ioannidis O, Angelopoulos S, Tsalis KG. A rare case of primary hyperparathyroidism caused by a giant Solitary parathyroid adenoma. Am J Case Rep. 2018;19:1334\u20137. https:\/\/doi.org\/10.12659\/AJCR.911452.","journal-title":"Am J Case Rep"},{"issue":"2","key":"1836_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115\u201325. https:\/\/doi.org\/10.1038\/nrendo.2017.104. Epub 2017 Sep 8.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"1836_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Sol\u00f3rzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368. https:\/\/doi.org\/10.1001\/jamasurg.2016.2310.","journal-title":"JAMA Surg"},{"issue":"12","key":"1836_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1634\/theoncologist.2010-0158","volume":"15","author":"LF Morris","year":"2010","unstructured":"Morris LF, Zelada J, Wu B, Hahn TJ, Yeh MW. Parathyroid surgery in the elderly. Oncologist. 2010;15(12):1273\u201384. https:\/\/doi.org\/10.1634\/theoncologist.2010-0158. Epub 2010 Dec 15.","journal-title":"Oncologist"},{"issue":"6","key":"1836_CR6","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1245\/s10434-014-4201-9","volume":"22","author":"H Wachtel","year":"2015","unstructured":"Wachtel H, Cerullo I, Bartlett EK, Kelz RR, Karakousis GC, Fraker DL. What can we learn from intraoperative parathyroid hormone levels that do not Drop appropriately? Ann Surg Oncol. 2015;22(6):1781\u20138. https:\/\/doi.org\/10.1245\/s10434-014-4201-9. Epub 2014 Oct 30.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1836_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00423-012-1004-y","volume":"398","author":"E Karakas","year":"2013","unstructured":"Karakas E, M\u00fcller HH, Schlosshauer T, Rothmund M, Bartsch DK. Reoperations for primary hyperparathyroidism\u2013improvement of outcome over two decades. Langenbecks Arch Surg. 2013;398(1):99\u2013106. https:\/\/doi.org\/10.1007\/s00423-012-1004-y. Epub 2012 Sep 23.","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"1836_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00268-002-6664-2","volume":"26","author":"C Hasse","year":"2002","unstructured":"Hasse C, Sitter H, Brune M, Wollenteit I, Nies C, Rothmund M. Quality of life and patient satisfaction after reoperation for primary hyperparathyroidism: analysis of long-term results. World J Surg. 2002;26(8):1029\u201336. https:\/\/doi.org\/10.1007\/s00268-002-6664-2. Epub 2002 Jun 13.","journal-title":"World J Surg"},{"key":"1836_CR9","doi-asserted-by":"publisher","unstructured":"Udelsman R, \u00c5kerstr\u00f6m G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3595\u2013\u2009606. https:\/\/doi.org\/10.1210\/jc.2014-2000. Epub 2014 Aug 27.","DOI":"10.1210\/jc.2014-2000"},{"issue":"2","key":"1836_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/lary.20706","volume":"120","author":"VN Young","year":"2010","unstructured":"Young VN, Osborne KM, Fleming MM, Flynn MB, Goldstein RE, Bumpous JM. Parathyroidectomy in the elderly population: does age really matter? Laryngoscope. 2010;120(2):247\u201352. https:\/\/doi.org\/10.1002\/lary.20706.","journal-title":"Laryngoscope"},{"key":"1836_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-26794-4_46","volume-title":"Medical and Surgical Treatment of Parathyroid diseases","author":"N\u00c1 Jobet","year":"2017","unstructured":"Jobet N\u00c1, Moreno MA. Complications of parathyroid surgery. In: Stack B Jr, Bodenner D, editors. Medical and Surgical Treatment of Parathyroid diseases. Cham: Springer; 2017. https:\/\/doi.org\/10.1007\/978-3-319-26794-4_46."},{"issue":"12","key":"1836_CR12","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Kleerekoper FG-H, Neer M, Peacock R, Rastad M, Silverberg J, Udelsman SJ, Wells R. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):5353\u201361. https:\/\/doi.org\/10.1210\/jc.2002-021370.","journal-title":"J Clin Endocrinol Metab"},{"key":"1836_CR13","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Khan AA, Clarke BL, Mannstadt M, Potts JT, Brandi ML. The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism. J Bone Miner Res. 2022;37(11):2290\u20132292. https:\/\/doi.org\/10.1002\/jbmr.4670. Epub 2022 Oct 17.","DOI":"10.1002\/jbmr.4670"},{"key":"1836_CR14","doi-asserted-by":"publisher","unstructured":"Alherabi AZ, Marglani OA, Alfiky MG, Raslan MM, Al-Shehri B. Percutaneous ultrasound-guided alcohol ablation of solitary parathyroid adenoma in a patient with primary hyperparathyroidism. Am J Otolaryngol. 2015 Sep-Oct;36(5):701\u20133. https:\/\/doi.org\/10.1016\/j.amjoto.2015.04.006. Epub 2015 Apr 15.","DOI":"10.1016\/j.amjoto.2015.04.006"},{"issue":"8","key":"1836_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/hcn062","volume":"101","author":"C Cappelli","year":"2008","unstructured":"Cappelli C, Pelizzari G, Pirola I, Gandossi E, De Martino E, Delbarba A, Agosti B, Agabiti Rosei E, Castellano M. Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism. QJM. 2008;101(8):657\u201362. https:\/\/doi.org\/10.1093\/qjmed\/hcn062. Epub 2008 May 22.","journal-title":"QJM"},{"key":"1836_CR16","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. https:\/\/doi.org\/10.1136\/bmj.c332.","journal-title":"BMJ"},{"key":"1836_CR17","doi-asserted-by":"publisher","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3580-94. https:\/\/doi.org\/10.1210\/jc.2014-1415. Epub 2014 Aug 27.","DOI":"10.1210\/jc.2014-1415"},{"key":"1836_CR18","doi-asserted-by":"publisher","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom. 2013 Jan-Mar;16(1):33\u20139. https:\/\/doi.org\/10.1016\/j.jocd.2012.12.001.","DOI":"10.1016\/j.jocd.2012.12.001"},{"issue":"9","key":"1836_CR19","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00345-020-03333-6","volume":"39","author":"R Dotzauer","year":"2021","unstructured":"Dotzauer R, B\u00f6hm K, Brandt MP, Sparwasser P, Haack M, Frees SK, Kamal MM, Mager R, J\u00e4ger W, H\u00f6fner T, Tsaur I, Haferkamp A, Borgmann H. Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic. World J Urol. 2021;39(9):3139\u201345. https:\/\/doi.org\/10.1007\/s00345-020-03333-6. Epub 2020 Jul 4.","journal-title":"World J Urol"},{"key":"1836_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/jrms.JRMS_553_","volume":"25","author":"AA Yazdani","year":"2020","unstructured":"Yazdani AA, Khalili N, Siavash M, Shemian A, Goharian AR, Karimifar M, Tavakoli B, Yazdi M. Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: a prospective self-controlled study. J Res Med Sci. 2020;25:93. https:\/\/doi.org\/10.4103\/jrms.JRMS_553_.","journal-title":"J Res Med Sci"},{"issue":"999","key":"1836_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/pgmj.2008.070177","volume":"85","author":"P Iglesias","year":"2009","unstructured":"Iglesias P, D\u00edez JJ. Current treatments in the management of patients with primary hyperparathyroidism. Postgrad Med J. 2009;85(999):15\u201323. https:\/\/doi.org\/10.1136\/pgmj.2008.070177.","journal-title":"Postgrad Med J"},{"issue":"3","key":"1836_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0194599816644727","volume":"155","author":"C Meltzer","year":"2016","unstructured":"Meltzer C, Klau M, Gurushanthaiah D, Titan H, Meng D, Radler L, Sundang A. Risk of complications after Thyroidectomy and Parathyroidectomy: a Case Series with Planned Chart Review. Otolaryngol Head Neck Surg. 2016;155(3):391\u2013401. Epub 2016 May 3.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1836_CR23","unstructured":"Farndon JR. Postoperative complications of parathyroidectomy. In: Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6967\/"},{"key":"1836_CR24","doi-asserted-by":"publisher","unstructured":"Harman CR, Grant CS, Hay ID, Hurley DL, van Heerden JA, Thompson GB, Reading CC, Charboneau JW. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery. 1998;124(6):1011-9; discussion 1019-20. https:\/\/doi.org\/10.1067\/msy.1998.91826","DOI":"10.1067\/msy.1998.91826"},{"key":"1836_CR25","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9. https:\/\/doi.org\/10.1210\/jc.2014-1413. Epub 2014 Aug 27.","DOI":"10.1210\/jc.2014-1413"},{"issue":"2","key":"1836_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/s0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol. 2010;54(2):106\u20139. https:\/\/doi.org\/10.1590\/s0004-27302010000200004.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6","key":"1836_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","volume":"44","author":"P Anagnostis","year":"2021","unstructured":"Anagnostis P, Vaitsi K, Veneti S, Potoupni V, Kenanidis E, Tsiridis E, Papavramidis TS, Goulis DG. Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies. J Endocrinol Invest. 2021;44(6):1127\u201337. https:\/\/doi.org\/10.1007\/s40618-020-01447-7. Epub 2020 Oct 19.","journal-title":"J Endocrinol Invest"},{"key":"1836_CR28","doi-asserted-by":"publisher","unstructured":"Verg\u00e8s B, Cercueil JP, Jacob D, Vaillant G, Brun JM. Traitement des ad\u00e9nomes parathyro\u00efdiens par alcoolisation sous contr\u00f4le \u00e9chographique [Treatment of parathyroid adenomas with ethanol injection under ultrasonographic guidance]. Ann Chir. 2000;125(5):457\u2013\u200960; discussion 460-1. French. https:\/\/doi.org\/10.1016\/s0003-3944(00)00221-2","DOI":"10.1016\/s0003-3944(00)00221-2"},{"issue":"1","key":"1836_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21037\/gs-22-546","volume":"13","author":"PP Issa","year":"2024","unstructured":"Issa PP, Kandil E, Lee GS. Radiofrequency ablation as a treatment modality for primary hyperparathyroidism: a systematic literature review. Gland Surg. 2024;13(1):87\u201399. https:\/\/doi.org\/10.21037\/gs-22-546. Epub 2023 Jun 14.","journal-title":"Gland Surg"},{"issue":"1","key":"1836_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12902-024-01583-8","volume":"24","author":"K Govind","year":"2024","unstructured":"Govind K, Paruk IM, Motala AA. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa. BMC Endocr Disord. 2024;24(1):53. https:\/\/doi.org\/10.1186\/s12902-024-01583-8.","journal-title":"BMC Endocr Disord"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01836-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01836-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01836-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T03:58:11Z","timestamp":1737691091000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01836-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01836-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was accepted by the ethics committee of the Isfahan University of Medical Sciences, with the ethical code: IR.MUI.MED.1400.003 and registration in the clinical trials databases with the IRCT20210204050241N1 code. Written informed consent was obtained from all participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}